Trusted by 10,000+ Scientists since 2006


30 Item(s)

per page

Set Descending Direction
Catalog No. Product Name Application Product Information
A14958 SALE


PPAR agonist
GW0742 is a selective agonist of PPARδ with EC50 value of 1.1 nM.
A15836 SALE


PPAR agonist
BMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR) alpha agonist, with an EC(50) of 10 nM for human PPARalpha and approximately 410-fold selectivity vs human PPARgamma in PPAR-GAL4 transactivation assays.


PPAR agonist
GW1929 is a synthetic peroxisome proliferator-activated receptor-?? (PPAR??) agonist with IC50 of 6.2 nM and 13 nM for human and mouse, respectively.
A11588 SALE


PPAR-γ antagonist
T0070907 was identified as a potent and selective PPARgamma antagonist. With an apparent binding affinity (concentration at 50% inhibition of [(3)H]rosiglitazone binding or IC(50)) of 1 nm, T0070907 covalently modifies PPARgamma on cysteine 313 in helix 3 of human PPARgamma2.


PPAR-α/γ agonist
Aleglitazar is a new dual PPAR-α/γ agonist with IC50 of 2.8 nM/4.6 nM.
A15454 SALE


PPAR agonist
Elafibranor is an agonist of the peroxisome proliferator-activated Receptor-α and -δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening.


PPARγ Agonist
CDDO-Im is a novel synthetic triterpenoid more potent than its parent compound CDDO both in vitro and in vivo; PPARγ Agonist.

DG172 dihydrochloride

PPARβ/δ inverse agonist
DG-172 is an orally active potent PPARβ/δ inverse agonist (IC50 = 26.9 nM). DG-172 inhibits Angptl4 gene expression in mouse myoblasts (IC50 = 9.5 nM) in vitro.
A15013 SALE


PPAR-γ partial agonist
Balaglitazone is a novel partial agonist of PPAR-gamma (γ).

Choline Fenofibrate

CYP2C19/CYP2B6 inhibitor
Choline Fenofibrate (ABT-335) is the choline salt of fenofibric acid under clinical development as a combination therapy with rosuvastatin for the management of dyslipidemia.

Inolitazone dihydrochloride

PPARγ agonist
Inolitazone dihydrochloride is a novel high-affinity PPARγ agonist, which activates PPARγ with an EC50 about 1/50 that of rosiglitazone and has no effect on RIE cells.

Fenofibric acid

Fenofibric acid is a fibrate that acts as a lipid-lowering agent, decreasing low-density lipoprotein cholesterol and triglycerides.


Fenofibrate is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease.


PPAR agonist
Bezafibrate is the first clinically tested dual and pan-PPAR co-agonist.
A10809 SALE

Rosiglitazone maleate

PPAR agonist
Rosiglitazone maleate, an antidiabetic drug, works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin.


PPARα antagonist
GW6471 is a PPARα antagonist, shown to completely inhibit GW409544-induced activation of PPARα.
A11137 SALE


Peroxisome Proliferator
Cetaben is a unique, PPARα-independent peroxisome proliferator with hypolipidemic activity that inhibits cholesterol synthesis in the human hepatoma Hep-G2 cells resulting in reversible changes in Golgi morphology.
A11680 SALE

Pioglitazone (Actos)

PPARγ agonist
Pioglitazone selectively stimulates the nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) and to a lesser extent PPAR-α.
A10807 SALE

Rosiglitazone (BRL-49653)

PPAR agonist
Rosiglitazone works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin.
A11727 SALE


Ciprofibrate is a fibrate.
A11981 SALE


PPARγ agonist
Troglitazone is a selective PPARγ receptor agonist (EC50 values are 780 and 555 nM at murine and human PPARγ receptors respectively).

GW 7647

PPARα agonist
GW 7647 is a potent and highly selective PPARα agonist (EC50 values are 6, 1100 and 6200 nM for human PPARα, PPARγ and PPARδ receptors respectively).
A11983 SALE


PPARδ agonist
L-165,041 is a potent PPARδ agonist (Ki = 6 nM); displays > 100-fold selectivity for both mouse and human PPARδ receptors over other subtypes.
A11984 SALE

GW 9662

PPARγ antagonist
GW 9662 is a selective PPARγ antagonist (IC50 values are 3.3, 32 and 2000 nM for PPARγ, PPARα and PPARδ respectively).
A10424 SALE

Gemfibrozil (Lopid)

Gemfibrozil (Lopid) is a compound used to lower lipid levels.
A12360 SALE

pirinixic acid (WY 14643)

PPARα agonist
WY 14643 is a highly potent PPARα agonist.

GW 501516

PPARδ receptor agonist
GW501516 (GW1516 or GSK-516) is a drug that acts as a PPAR?? modulator.
A12391 SALE


PPAR antagonist
GSK-3787 is a potent and selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6).
A12392 SALE

GSK 0660

PPARδ antagonist
GSK 0660 is a selective PPARβ antagonist (IC50 values are 0.155, > 10 and ≥ 10 µM at PPARβ, PPARα and PPARγ respectively).

Clofibric Acid

PPARα agonist
Clofibric acid is a PPARα agonist and hypolipidemic agent.

30 Item(s)

per page

Set Descending Direction